guardian-logo-rss.c45beb1bafa34b347ac333af2e6fe23f

‘Female viagra': FDA panel backs Flibanserin with safety restriction

A coalition of women’s groups and the drug’s manufacturer advocated for approval of the pill, Flibanserin – but others advised agency to remain cautious

Government health experts are backing an experimental drug intended to boost the female sex drive, but stress that it must carry safety restrictions to manage side effects including fatigue, low blood pressure and fainting.

The Food and Drug Administration panel voted 18-6 in favor of approving Sprout Pharmaceutical’s daily pill flibanserin, on the condition that its manufacturer develops a plan to limit safety risks.

Continue reading…

Leave a Reply

Your email address will not be published. Required fields are marked *

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>